Squarepoint Ops LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 209 filers reported holding SAGE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,418,477
-45.5%
68,925
+24.6%
0.00%
-50.0%
Q2 2023$2,600,864
-21.7%
55,314
-30.1%
0.01%
-42.9%
Q1 2023$3,321,721
-25.5%
79,164
-32.3%
0.01%
-22.2%
Q4 2022$4,461,274
-25.6%
116,971
-23.6%
0.02%
-40.0%
Q3 2022$5,995,000
+74.6%
153,083
+44.0%
0.03%
+57.9%
Q2 2022$3,434,000
+21.6%
106,325
+24.6%
0.02%
+58.3%
Q1 2022$2,825,000
-9.3%
85,341
+16.5%
0.01%
+50.0%
Q4 2021$3,116,000
+118.8%
73,255
+192.3%
0.01%
+60.0%
Q2 2021$1,424,000
+59.5%
25,061
+142.7%
0.01%
-28.6%
Q4 2020$893,000
+64.5%
10,325
+16.2%
0.01%0.0%
Q3 2020$543,000
-89.3%
8,882
-92.7%
0.01%
-91.5%
Q2 2020$5,094,000
+1725.8%
122,500
+1160.2%
0.08%
+1071.4%
Q1 2020$279,000
-79.4%
9,721
+0.8%
0.01%
-41.7%
Q3 2019$1,353,000
-57.0%
9,645
-70.6%
0.01%
-67.6%
Q4 2018$3,145,000
-43.0%
32,830
-16.0%
0.04%
-43.9%
Q3 2018$5,518,000
-41.8%
39,065
-35.5%
0.07%
-47.6%
Q2 2018$9,481,000
+1224.2%
60,573
+1262.7%
0.13%
+1045.5%
Q1 2018$716,000
+188.7%
4,445
+11.6%
0.01%
+120.0%
Q3 2017$248,000
-1.6%
3,982
+25.9%
0.01%0.0%
Q2 2017$252,000
-47.4%
3,163
-53.1%
0.01%
-61.5%
Q1 2017$479,000
+48.8%
6,746
+7.1%
0.01%0.0%
Q4 2016$322,000
-34.0%
6,300
-61.1%
0.01%
-56.7%
Q2 2016$488,000
+139.2%
16,200
+362.9%
0.03%
+36.4%
Q4 2015$204,000
+0.5%
3,500
-27.1%
0.02%
-56.9%
Q3 2015$203,0004,8000.05%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders